Impact Factor 4.137 | CiteScore 4.28
More on impact ›
The Gastrointestinal Cancers section aims at offering a wide and comprehensive approach to investigations concerning tumorigenesis, prevention, early detection and treatment of GI Tract neoplasia. Even though the molecular machinery triggering and sustaining GI tract carcinogenesis and the morphogenetic pathways leading to cancer is, at least in part, well-established, knowledge has only been incompletely translated to the single patient care and population-based interventions, in spite of the technological novelties in endoscopy and imaging of GI Tract tumors and their tailored treatments.
The ultimate effort of the section is, therefore, to support multidisciplinary research in order to speed up clinical applications of biological advances. For these reasons Gastrointestinal Cancers specifically welcomes contributions on the following topics:
While we welcome meta-analyses and descriptive studies (including those submitted as Original Research), these should be based on rigorous statistical methods or systematic reviews, and must bring new insights into the mechanisms of carcinogenesis. Furthermore, manuscripts focusing on cancer risk factors and stratification are not in scope for this section and should be submitted to Cancer Epidemiology and Prevention of Frontiers in Oncology.
In silico studies must be validated with a cell line study.
Submissions that are surgical in nature are not in scope for this section and should be submitted to the Surgical Oncology Section of Frontiers in Oncology.
Case Reports should include correlative data and expand the current knowledge on the pathophysiological and clinical manifestations of cancer while discussing the cellular and molecular levels of the disease.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Gastrointestinal Cancers welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Gastrointestinal Cancers, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Gastrointestinal Cancers will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Oncology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org